Quest Diagnostics' $2.4M Blood Techs OT Row Deal Gets Nod
A California federal judge on Tuesday gave preliminary approval to Quest Diagnostics Clinical Laboratories' $2.35 million deal with a settlement class of 2,600 phlebotomists who claimed that, due to understaffing, blood...To view the full article, register now.
Already a subscriber? Click here to view full article